US FDA Reorg: Defining The “Central” Purpose Of A Commissioner

Scott Gottlieb will formally implement a new structure for the Office of the Commissioner just days before he departs from the job. That may be odd timing, but the new structure is in many ways a perfect capstone for Gottlieb’s tenure.

Manometers-Cooling-System

The timing certainly is odd: US FDA Commissioner Scott Gottlieb is announcing the formal implementation of a new structure for his office will take effect March 31 – just days before he will be leaving the job April 5.

The major element of the commissioner-level restructuring is the unwinding of the “directorate” approach set up by Margaret Hamburg at...

More from US FDA

More from Agency Leadership